TMOD-18. EXPLORING THE FACTORS LEAD TO SUCCESS OF CAR T-CELL THERAPY IN GLIOBLASTOMA WITH COMPUTATIONAL MODELING AND IN VITRO DATA

Chimeric antigen receptor (CAR) T-cell therapy is an emerging targeted immunotherapy which has shown success in liquid cancers such as leukemias. CAR T-cells are also being used for the treatment of solid tumors such as glioblastoma, which is a primary brain tumor. Ongoing phase I trials have been d...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Sahoo, Prativa, Yang, Xin, Abler, Daniel, Maestrini, Davide, Adhikarla, Vikram, Brown, Christine E, Rockne, Russell
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Tumor Models
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846140/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1117
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares